PT  - JOURNAL ARTICLE
AU  - Rizzo, Toni
ED  - van der Graaf, Winette
TI  - Single-Agent Doxorubicin versus Doxorubicin Plus Ifosfamide in Advanced Soft Tissue Sarcoma
DP  - 2012  01
TA  - MD Conference Express
PG  - 9--10
VI  - 12
IP  - 15
4099  - http://mdc.sagepub.com/content/12/15/9.2.short
4100  - http://mdc.sagepub.com/content/12/15/9.2.full
AB  - Patients with locally advanced unresectable or metastatic soft tissue sarcoma have poor outcomes. Palliative chemotherapy is standard treatment for these patients, but it generally results in considerable toxicity. Previous studies have compared single-agent doxorubicin with doxorubicin plus ifosfamide, but the optimal doses remain unclear. This article discusses the European Organisation for Research and Treatment of Cancer 62012 Phase 3 study [NCT00061984] in patients with advanced soft tissue sarcoma.